Table 2.
Covariate | Univariate | P value | Holm* | Multivariate** | P value | Holm* |
---|---|---|---|---|---|---|
Patient age (years) | 0.98 | <0.001 | 0.002 | 0.68 | 0.001 | 0.002 |
PSA (ng/mL) | 0.59 | <0.001 | 0.002 | 0.77 | <0.001 | 0.002 |
Prostate Volume (cc)** | −1.22 | <0.001 | 0.002 | −2.04 | <0.001 | 0.002 |
PSA Density (ng/mL/cc)** | 0.004 | <0.001 | 0.002 | −0.0008 | 0.67 | 0.008 |
Year of biopsy | 0.11 | 0.014 | 0.003 | 0.02 | 0.85 | 0.013 |
Number of cores taken | −0.33 | 0.27 | 0.007 | 0.58 | 0.26 | 0.005 |
Biopsy cohort*** | −0.08 | 0.004 | 0.002 | −0.14 | 0.03 | 0.003 |
Race | ||||||
Caucasian | 0.05 | 0.04 | 0.003 | 0.19 | 0.04 | 0.003 |
Asian | −0.24 | 0.05 | 0.004 | 0.007 | 0.94 | 0.025 |
African American | 0.15 | 0.01 | 0.003 | 0.24 | 0.03 | 0.003 |
Hispanic | −0.09 | 0.35 | 0.008 | 0.08 | 0.51 | 0.006 |
Other or Unknown | −0.06 | 0.03 | 0.003 | 0.08 | 0.44 | 0.006 |
Diagnosing physician**** | ||||||
1 (N=115) | 0.05 | 0.13 | 0.005 | 0.18 | 0.004 | 0.003 |
2 (N=18) | −0.18 | 0.01 | 0.003 | −0.12 | 0.65 | 0.007 |
3 (N=7) | 0.06 | .65 | 0.050 | −0.01 | 0.94 | 0.050 |
4 (N=69) | −0.06 | 0.18 | 0.006 | 0 | 0.14 | 0.004 |
5 (N=1) | −0.44 | 0.38 | 0.010 | 0 | 0.002 | 0.002 |
6 (N=88) | 0.06 | 0.16 | 0.005 | 0.61 | 0.07 | 0.004 |
7 (N=2) | 0.56 | 0.26 | 0.006 | 0 | 0.04 | 0.003 |
8 (N=102) | −0.15 | 0.42 | 0.013 | 0.04 | 0.84 | 0.010 |
9 (N=3) | −0.07 | 0.09 | 0.004 | 0 | 0.04 | 0.004 |
10 (N=7) | −0.22 | 0.09 | 0.004 | 0.04 | 0.91 | 0.017 |
11 (N=3) | −0.08 | 0.55 | 0.025 | 0 | <0.001 | 0.002 |
12 (N=10) | 0.23 | 0.42 | 0.017 | 0.55 | 0.23 | 0.005 |
13 (N=533) | −0.28 | 0.04 | 0.003 | −0.35 | 0.03 | 0.003 |
Represents statistical significance threshold of alpha = 0.05 with Holm stepdown correction.
Analysis performed with the 820 patients with prostate volume data available.
Categorical variable represented as FHB – 1, TMB – 0.
Physician 8 performed all TMB and no FHB.